Vicriviroc in Combination Treatment With an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E3).

Trial Profile

Vicriviroc in Combination Treatment With an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E3).

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Sep 2013

At a glance

  • Drugs Vicriviroc (Primary)
  • Indications HIV-1 infections
  • Focus Registrational; Therapeutic Use
  • Acronyms VICTOR-E3
  • Most Recent Events

    • 18 Apr 2011 Actual patient number (506) and actual end date (1 March, 2011) reported by ClinicalTrials.gov.
    • 18 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
    • 11 Mar 2011 Planned end date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top